Products for Research Use Only
RegisterLogin

Proglumide (sodium)

CAT: 0804-HY-103354-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-103354-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Proglumide sodium is a nonpeptide and orally active cholecystokinin (CCK) -A/B receptors antagonist. Proglumide sodium selective blocks CCK’s effects in the central nervous system (CNS) . Proglumide sodium has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide sodium also has antiepileptic and antioxidant activities[1][2][3][4][5].
CAS Number
99247-33-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Cholecystokinin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer; Endocrinology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/proglumide-sodium.html
Concentration
10mM
Purity
99.58
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(O[Na])CCC(NC(C1=CC=CC=C1)=O)C(N(CCC)CCC)=O
Molecular Formula
C18H25N2NaO4
Molecular Weight
356.39
Precautions
H302, H315, H319
References & Citations
[1]Ahmad M, et al. The effects of quinacrine, proglumide, and pentoxifylline on seizure activity, cognitive deficit, and oxidative stress in rat lithium-pilocarpine model of status epilepticus. Oxid Med Cell Longev. 2014;2014:630509.|[2] Iwamoto Y, et al. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini. Gastroenterol Jpn. 1984 Feb;19 (1) :53-8.|[3]González-Puga C, et al. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin. J Pineal Res. 2005 Oct;39 (3) :243-50.|[4]Bunney BS, et al. Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system. Ann N Y Acad Sci. 1985;448:345-51.|[5]Tariq M, et al. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats. J Pharmacol Exp Ther. 1987 May;241 (2) :602-7.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName
HY-B1330-01Proglumide
HY-B1330R-01Proglumide (Standard)
HY-103354AProglumide (hemicalcium)
HY-W791754Paeonolsilate (sodium)
HY-W272811Camphorsulfonate (sodium)
HY-W094710-01Sodium diacetate
HY-W050026APhenylacetylglutamine (sodium)
HY-W009640AMofebutazone (sodium)
HY-22274-01DMPG (sodium)
HY-17474A-01Parecoxib (Sodium)

Alternative Products

CatalogName
T23185Proglumide sodium
B5121-100Proglumide sodium salt
A13713-500Proglumide sodium salt 500mg
A13713-50Proglumide sodium salt 50mg
A13713-100Proglumide sodium salt 100mg
BA5273-50Proglumide

Popular Products